Archives
Distinct Roles of GluN2A/B in Trigeminal Ganglion Sensitizat
2026-05-31
This study elucidates how GluN2A and GluN2B subunits of the NMDA receptor differentially regulate connexin and pannexin expression in trigeminal ganglia during TMJ-induced orofacial allodynia. By mapping distinct signaling pathways, including ERK1/2 and broader MAPK cascades, the findings highlight new molecular targets for pain modulation and offer mechanistic clarity for future therapeutic strategies.
Perospirone (SM-9018 freebase): Reliable Solutions for Cell
2026-05-30
This article addresses real laboratory challenges in cell viability, proliferation, and ion channel assays, demonstrating how Perospirone (SM-9018 freebase) (SKU BA5009) from APExBIO delivers reproducible, data-driven solutions. Scenario-based Q&A blocks provide practical guidance on experimental design, protocol optimization, and product selection, grounding every recommendation in peer-reviewed research and validated performance data.
Topotecan (B4982): Precision Strategies for Translational Ca
2026-05-29
Explore how Topotecan, a potent topoisomerase I inhibitor, enables precision-driven translational cancer research beyond standard protocols. This article offers unique, evidence-backed guidance for experimental design and clinical translation.
Moxifloxacin: Fluoroquinolone Antibiotic for Advanced Toxici
2026-05-29
Moxifloxacin from APExBIO empowers labs to dissect antibiotic toxicity, cellular proliferation, and metabolic responses with precision. This article delivers actionable workflows, troubleshooting strategies, and direct comparisons with next-generation gyrase inhibitors—enabling reproducible and insightful assays in both mammalian and bacterial systems.
Angiotensin II Drives M1 Macrophage Polarization via Cx43/NF
2026-05-28
This study demonstrates that Angiotensin II promotes M1-type polarization in RAW264.7 macrophages through the connexin 43/NF-κB (p65) signaling pathway. Selective inhibition of Cx43 hemichannels attenuates pro-inflammatory responses, offering mechanistic insight for inflammation and atherosclerosis research.
Mianserin Hydrochloride (SKU A1796): Reliable Cell Assay Sol
2026-05-28
This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays by providing scenario-driven guidance for using Mianserin Hydrochloride (SKU A1796). Integrating evidence from peer-reviewed studies and product specifications, it demonstrates how APExBIO’s compound advances experimental reproducibility, workflow safety, and data interpretation in psychiatric and antipathogenic research.
HSC70 Enables TGEV Entry via Clathrin-Mediated Endocytosis
2026-05-27
This study reveals a previously unrecognized function of the TGEV membrane (M) protein: facilitating viral entry by recruiting host HSC70 and engaging clathrin-mediated endocytosis. These findings highlight a novel host-pathogen interaction that expands our understanding of coronavirus infection mechanisms and suggests new research avenues for antiviral strategy development.
Fucoidan: Applied Workflows in Cancer and Chemotherapy Resea
2026-05-27
Fucoidan, a sulfated α-L-fucan from brown seaweed, offers robust anticancer and immune-modulating properties—now proven to mitigate chemotherapy-induced liver injury by targeting the gut–liver axis. This article delivers actionable protocols, troubleshooting strategies, and cross-domain insights for researchers leveraging APExBIO’s high-purity Fucoidan.
SCH772984: ERK1/2 Inhibitor Workflow Optimization in Tumor M
2026-05-26
SCH772984 empowers researchers to selectively inhibit ERK1/2 with nanomolar precision, enabling reproducible MAPK/ERK pathway dissection across diverse cancer models—including BRAF, NRAS, and KRAS mutant lines. This guide delivers actionable protocols, troubleshooting insights, and strategic assay enhancements for translational oncology workflows.
Artesunate: Workflow-Driven Advances in Cancer Research Mode
2026-05-26
Artesunate, a semi-synthetic artemisinin derivative, enables precise interrogation of cancer cell death mechanisms via dual ferroptosis induction and AKT/mTOR pathway inhibition. By leveraging data-driven protocols and troubleshooting strategies, researchers can maximize assay reproducibility and accelerate translational findings in small cell lung and esophageal squamous cell carcinoma models.
Pseudo-UTP in mRNA Synthesis: Scientific Advances and Resear
2026-05-25
Explore the science behind pseudo-modified uridine triphosphate (Pseudo-UTP) in cutting-edge mRNA synthesis. This article reveals how pseudouridine modification transforms RNA stability, immunogenicity, and translational applications, offering distinct insights and practical guidance for modern RNA research.
Amikacin (BAY416651): Applied Workflows in Antibiotic Resist
2026-05-25
Harness Amikacin (BAY416651) to unlock advanced workflows in bacterial protein synthesis inhibition and antibiotic resistance modeling, from targeted delivery in granuloma models to dissecting resistance in multidrug-resistant strains. This guide offers protocol enhancements, troubleshooting strategies, and actionable insights for maximizing research reproducibility.
Advancing In Vitro Drug Response Evaluation in Cancer Resear
2026-05-24
Schwartz's dissertation introduces a refined approach to distinguishing between proliferative arrest and cell death in in vitro anti-cancer drug assays. By clarifying the interpretation of viability metrics, the study enables more accurate evaluation of drug efficacy and mechanism, with practical implications for the design and analysis of preclinical cancer research.
RNA Clean and Concentrator Kit: Precision RNA Purification S
2026-05-23
Unlock rapid, high-yield RNA purification from enzymatic reactions with the RNA Clean and Concentrator Kit. This spin column platform, trusted by APExBIO, streamlines workflows for NAFLD research and beyond—delivering reproducible results, robust contaminant removal, and seamless compatibility with advanced molecular assays.
Refining In Vitro Drug Response Metrics in Cancer Research
2026-05-22
Schwartz’s dissertation critically examines how in vitro drug response metrics—specifically, relative viability and fractional viability—differ in measuring cell proliferation arrest versus cell death. By dissecting these endpoints across diverse anticancer compounds, the study provides methodological improvements for evaluating agents such as artemisinin derivatives in cancer models, offering more precise experimental readouts for drug development.
607 records 20/41 page Previous Next First page 上5页 1617181920 下5页 Last page